Send to

Choose Destination
Crit Care. 2006;10(6):316.

Drotrecogin alfa (activated) should not be used in patients with severe sepsis and low risk for death.

Author information

Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center